Moderna May Be Facing Its Toughest Moment Ever. Time to Sell?
Moderna still has big ambitions -- beyond the coronavirus vaccine -- that could pay off in a few years.
Stay updated with breaking news from While Moderna. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Moderna still has big ambitions -- beyond the coronavirus vaccine -- that could pay off in a few years.
/PRNewswire/ -- Promosome LLC, represented by Susman Godfrey, has filed major patent infringement actions against pharmaceutical behemoths Moderna, Pfizer, and...
A cancer vaccine deal with pharma heavyweight Merck is lighting a fire underneath the biotech's shares today.
Wall Street thinks the bear market has pushed this top biotech stock down too far.
The recently approved Pune-based Gennova Biopharmaceuticals' two-dose mRNA Covid-19 vaccine, expected to be soon available in the country, is likely to see low penetration in the Indian market, according to a report on Monday.The jab ...